New health laws ‘may hit Adcock’

Share price has gone up by 22% since the start of 2017, but there was a drop of 1.5% last week, breaking two consecutive weeks of gains

Day hospitals offer many advantages, but South Africans are slow on the uptake

Undergoing short surgical and diagnostic procedures at these facilities cuts both costs and the risk of cross-infection, but occupancy levels are at just ...

Thriving Aspen seeks more expansion, and is eyeing women’s health

CEO Stephen Saad says the company is ‘in a great space’ to make further acquisitions ‘because we have our teams in the right place and ...

Mediclinic buys stake in Swiss clinic

The $71m deal will strengthen the Private hospital group’s presence in the Swiss market

Want to save on medical aid costs? Choose a smaller scheme

However, GTC has found that the larger schemes are attracting the bulk of new members mainly because of their reputations

Aspen shares stable as market sees big picture

The market is keeping a close eye on the global move to review pharmaceutical practices, says analyst

EXCLUSIVE: Analysis shows Aspen kept price rises to legal limit

The local scenario is in sharp contrast to Europe, where Aspen is being investigated by competition authorities for implementing steep price hikes

Aspen loses Italy appeal over cancer drug prices

The Italian case relates to the prices of a portfolio of off-patent cancer drugs Aspen acquired from GlaxoSmithKline years ago

Mediclinic shares down nearly 30% as the private hospital group still has to heal

JP Morgan report by analysts says the longer-term structural outlook and ultimate earnings recovery are good

Watchdog probes Aspen for cancer drug pricing

The African manufacturer is being investigated in Europe, as Roche and Pfizer also come under scrutiny in SA

Life Healthcare CE resigns after three years at the helm

Private hospital group says André Meyer will step down by the end June to pursue other interests

Ombud sides with policy holder in his fight with Clientele Life

The long-term insurance ombudsman overrides a clause about waiting periods, forcing the insurer to pay for eight days of hospitalisation

Ascendis seals deals in Eastern Europe

The final price for Cyprus’s NHP Natural Health Pharma depends on its performance over the next three years

Counting the costs as investments in the Middle East drag on Mediclinic’s profit

CEO Danie Meintjes explains Mediclinic’s strained Middle East strategy to Giulietta Talevi

Mediclinic hospitals and Cure Day clinics get prestigious accreditation

Four South African clinics have been recognised by the Council for Health Service Accreditation of Southern Africa

Aspen shares rise as DA pulls back demand for probe

The DA had asked the Competition Commission and the Medicines Control Council to investigate Aspen’s market conduct

Need to stay informed?

Subscribe from R120 per month to get the best of Business Day, the Financial Mail, Business Times, RDM and more, along with perks such as exclusive Financial Times content.

Investors Monthly is a magazine published by Times Media, Media Division included in the Financial Mail on the last Thursday of the month.